The global gastrointestinal devices market is projected to grow at a CAGR of ~7% during the forecast period. This expansion is fueled by an aging population, an increasing prevalence of gastrointestinal diseases, and a surge in minimally invasive procedures. The rise in early disease screening programs, especially for colorectal cancer, is significantly driving device adoption. However, factors such as stringent regulatory approvals and the high cost of advanced GI procedures may limit market growth in certain regions.
Gastrointestinal (GI) devices refer to specialized instruments designed to diagnose, monitor, and treat digestive system disorders. These include endoscopic devices, biopsy forceps, enteral feeding tubes, hemostatic devices, and GI stents, among others. Their primary purpose is to provide minimally invasive solutions that improve diagnostic accuracy and therapeutic outcomes while reducing patient discomfort. The sector has witnessed continuous innovation, such as AI-powered endoscopic imaging, robotic-assisted surgeries, and advanced biodegradable stents, improving both patient care and procedural efficiency.
Click here to get our sample PDF report for Medical Devices market:
https://meditechinsights.com/gastrointestinal-devices-market/request-sample/
Increasing gastrointestinal disease burden fuelling market demand
One of the primary factors propelling the GI devices market is the growing burden of gastrointestinal diseases worldwide. Conditions such as colorectal cancer, gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD) are becoming more prevalent due to aging populations, dietary changes, and sedentary lifestyles. For instance, colorectal cancer remains a leading cause of cancer-related deaths, necessitating enhanced screening tools like high-definition endoscopes and AI-assisted lesion detection. Additionally, the increasing adoption of endoscopic procedures for early disease detection is driving demand for high-precision diagnostic and therapeutic devices. The trend toward outpatient and ambulatory GI procedures is also boosting market growth, as healthcare providers seek cost-effective and efficient solutions.
Technological innovations and AI-powered endoscopy driving market expansion
AI-driven advancements in gastrointestinal devices are revolutionizing diagnostics and treatment approaches. AI-powered endoscopy enhances polyp detection accuracy, reducing false-negative rates and improving early diagnosis of GI cancers. AI algorithms can analyze endoscopic images in real-time, offering decision support to physicians and improving procedural efficiency. Additionally, the development of robotic-assisted endoscopy is enhancing precision in minimally invasive GI surgeries, reducing recovery times and improving patient outcomes. Another key advancement is the adoption of single-use endoscopes, which eliminate the risk of cross-contamination and the need for costly sterilization processes. Innovations like biodegradable GI stents and 3D imaging-guided interventions further expand treatment options, making gastrointestinal procedures safer and more effective. These technological strides are enhancing clinical outcomes and accelerating market adoption across hospitals and ambulatory surgical centers.
Competitive Landscape Analysis
The global gastrointestinal devices market is marked by the presence of established and emerging market players such as Olympus Corporation; Fujifilm Holdings Corporation; Hoya Corporation (PENTAX Medical); Stryker Corporation; Boston Scientific Corporation; Medtronic Plc; Cook Group Incorporated; CONMED Corporation; Johnson & Johnson (Ethicon Inc.); and Cantel Medical Corporation among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Get PDF Report for Competitive Analysis:
https://meditechinsights.com/gastrointestinal-devices-market/request-sample/
Global Gastrointestinal Devices Market Segmentation
This report by Medi-Tech Insights provides the size of the global gastrointestinal devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product type, application, and end-user.
Market Size & Forecast (2023-2030), By Product Type, USD Million
• GI Endoscopes
• Laparoscopes
• Biopsy Devices
• Endoscopic Retrograde Cholangiopancreatography (ERCP)
• Others
Market Size & Forecast (2023-2030), By Application, USD Million
• Diagnostic
• Therapeutic
Market Size & Forecast (2023-2030), By End-user, USD Million
• Hospitals
• Diagnostic Centers
• Others
Market Size & Forecast (2023-2030), By Region, USD Million
• North America
o US
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o Rest of Asia Pacific
• Latin America
• Middle East & Africa
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
[email protected]
Top comments (0)